+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 12Years - 70Years
All Genders
ID07570862

Phase 2 Trial of FT819 Cell Therapy for Moderate-to-Severe Refractory Lupus Nephritis in Systemic Lupus Erythematosus

Led by Fate Therapeutics · Updated on 2026-09-14

53

Participants Needed

12

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the efficacy and safety of FT819, a treatment made of allogeneic T cells expressing a CD19-targeted CAR, for people with moderate-to-severe systemic lupus erythematosus SLE who have lupus nephritis LN that has not responded to at least two prior immunosuppressive treatments. This phase 2, open-label, single-arm trial focuses on participants aged 12 to 70 with biopsy-proven Class III or IV LN and active disease. The study aims to measure how many participants achieve complete renal response at 26 weeks. Participants will first undergo a screening period lasting up to 28 days. After screening, they will receive bendamustine treatment followed by a single intravenous infusion of FT819. The study will include efficacy, safety, and exploratory assessments at scheduled timepoints through 24 months of post-treatment follow-up. After this, participants will be monitored for safety and survival for up to 15 years in a long-term follow-up phase. Throughout the study, researchers will assess lupus nephritis activity using standard measures, including complete and partial renal responses, and clinician-reported outcomes such as SLEDAI-2K, BILAG, and PGA scores. Safety and disease activity evaluations will take place at predefined visits. The total duration of participation includes multiple assessments during the first two years and extended long-term monitoring up to 15 years to observe ongoing effects and survival.

CONDITIONS

Brief Title

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Research Team

F

Fate Clinical Trials

N

Natalie Shiff, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here